Steven Vickers

Steven Vickers is the Director at Sygnature Discovery, a position held since February 2004, with a focus on diabetes, obesity, and CNS techniques such as ex vivo receptor binding, autoradiography, microdialysis, neurochemistry, and behavior, as well as drug abuse liability evaluation, drug discovery, and preclinical R&D. Prior to this role, Steven Vickers worked as a Principal Scientist at Vernalis from 1997 to February 2004. Educational qualifications include studies at Queen Mary University of London and the University of Sussex.